The role of GABA_B receptors in depression and antidepressant-related behavioural responsesSLATTERY, David A; CRYAN, John F.Drug development research. 2006, Vol 67, Num 6, pp 477-494, issn 0272-4391, 18 p.Article

Adrenal corticosteroids, their receptors and hypertensionXIAO HU; BOLTEN, Charles W.Drug development research. 2006, Vol 67, Num 12, pp 871-883, issn 0272-4391, 13 p.Article

Computational identification and analysis of G protein-coupled receptor targetsFENG LU; LIN LI; ZHENRAN LIANG et al.Drug development research. 2006, Vol 67, Num 10, pp 771-780, issn 0272-4391, 10 p.Article

Mexiletine has a local anesthetic effect on sciatic nerve blockade in ratsCHENG, Kuang-I; SHIEH, Ja-Ping; LIN, Ching-Nan et al.Drug development research. 2006, Vol 67, Num 12, pp 905-909, issn 0272-4391, 5 p.Article

Non-viral gene therapy for diabetic retinopathyOSHITARI, Toshiyuki.Drug development research. 2006, Vol 67, Num 11, pp 835-841, issn 0272-4391, 7 p.Article

Methodology of clinical research : An overviewFLORIANI, Irene; TORRI, Valter.Drug development research. 2006, Vol 67, Num 3, pp 183-187, issn 0272-4391, 5 p.Article

The contribution of information technology : Towards a better clinical data managementCLIVIO, Luca; TINAZZI, Angelo; MANGANO, Simone et al.Drug development research. 2006, Vol 67, Num 3, pp 245-250, issn 0272-4391, 6 p.Article

Combined counseling and bupropion therapy for smoking cessation : Identification of outcome predictorsGRASSI, Maria Caterina; ENEA, Domenico; MARCHETTI, Rosanna et al.Drug development research. 2006, Vol 67, Num 3, pp 271-279, issn 0272-4391, 9 p.Article

Outcome research in diabetes : From theory to practice. Results of the QuED studyNICOLUCCI, Antonio; DE BERARDIS, Giorgia; FRANCIOSI, Monica et al.Drug development research. 2006, Vol 67, Num 3, pp 280-286, issn 0272-4391, 7 p.Article

Neuronal nicotinic acetylcholine receptors as a target for the treatment of neuropathic painMEYER, Michael D.Drug development research. 2006, Vol 67, Num 4, pp 355-359, issn 0272-4391, 5 p.Article

New drugs for metabolic syndrome. Part IIGURWITZ, David; RENDELL, Marc.Drug development research. 2006, Vol 67, Num 8, issn 0272-4391, 75 p.Conference Proceedings

Clinical significance of postprandial hyperglycemiaGERICH, John E; WOERLE, Hans J.Drug development research. 2006, Vol 67, Num 7, pp 587-590, issn 0272-4391, 4 p.Conference Paper

Our children and the metabolic syndromeDESMANGLES, Jean-Claude.Drug development research. 2006, Vol 67, Num 7, pp 602-606, issn 0272-4391, 5 p.Conference Paper

An innate immune regulatory factor (IIRF) prevents tumorogenesis in a murine melanoma challenge modelPARKER, Todd A; WILLEFORD, Kenneth O; PHARR, G. Todd et al.Drug development research. 2005, Vol 64, Num 4, pp 213-219, issn 0272-4391, 7 p.Article

Antinociceptive and antiinflammatory effects of ketoprofen are potentiated by a vitamin B mixture in the ratRODRFGUEZ-SILVERIO, Juan; AGUILAR-CARRASCO, José Carlos; REYES-GARCIA, Gerardo et al.Drug development research. 2005, Vol 64, Num 1, pp 66-70, issn 0272-4391, 5 p.Article

Comparison of the effects of cisplatin and a novel platinum polymer conjugate on the production of reactive oxygen species by human neutrophils in vitroSMIT, T; NEUSE, E. W; BECKER, P et al.Drug development research. 2005, Vol 66, Num 3, pp 204-209, issn 0272-4391, 6 p.Article

Histamine receptors as potential therapeutic targets to treat anxiety and depressionRABER, Jacob.Drug development research. 2005, Vol 65, Num 3, pp 126-132, issn 0272-4391, 7 p.Article

New drug targets for depression and anxiety. Part II: Focus on peptidesGURWITZ, David; WEIZMAN, Abraham.Drug development research. 2005, Vol 65, Num 4, issn 0272-4391, 163 p.Serial Issue

Neuroprotection by estrogen in animal models of ischemia and Parkinson's diseaseMERCHENTHALER, Istvan; SHUGHRUE, Paul J.Drug development research. 2005, Vol 66, Num 2, pp 172-181, issn 0272-4391, 10 p.Article

Generalization testing with atypical and typical antipsychotic drugs in rats trained to discriminate 5.0 mg/kg clozapine from vehicle in a two-choice drug discrimination taskPRUS, Adam J; PHILIBIN, Scott D; PEHRSON, Alan L et al.Drug development research. 2005, Vol 64, Num 1, pp 55-65, issn 0272-4391, 11 p.Article

Pharmacological studies on nitro-naproxen (naproxen-2-n itrooxyethylester)JAIN, Naveen K; PATIL, Chandrashekhar S; KARTASASMITA, R. E et al.Drug development research. 2004, Vol 61, Num 2, pp 66-78, issn 0272-4391, 13 p.Article

A₁ adenosine receptor antagonists, 3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4-(10H)-ones (ATBIs) and N-alkyl and N-acyl-(7-substituted-2-phenylimidazo[1,2-a][1,3,5]triazin-4-yl)amines (ITAs): Different recognition of bovine and human binding sitesDA SETTIMO, Federico; PRIMOFIORE, Giampaolo; TUSCANO, Daniela et al.Drug development research. 2004, Vol 63, Num 1, pp 1-7, issn 0272-4391, 7 p.Article

Cardiotoxin III induces apoptosis in T24 cells via reactive oxygen species-independent mitochondrial death pathwayCHIEN, Chine-Mine; YANG, Shene-Huei; LU, Mei-Chin et al.Drug development research. 2004, Vol 63, Num 4, pp 219-224, issn 0272-4391, 6 p.Article

Effect of ascorbic acid, dihydrolipoic acid, t-butylhydroquinone, and phenylbutylnitrone on mortality and neurological impairment induced by sequential common carotid artery sectioning in miceSANTIAGO-MEJIA, Jacinto; FUENTES-VARGAS, Monica; RIOS, Camilo et al.Drug development research. 2004, Vol 63, Num 4, pp 212-218, issn 0272-4391, 7 p.Article

Enhanced skin permeation of rofecoxib using topical Microemulsion gelDESAI, Kashappa Goud H.Drug development research. 2004, Vol 63, Num 1, pp 33-40, issn 0272-4391, 8 p.Article